Imperial College London

DrAileenRowan

Faculty of MedicineDepartment of Infectious Disease

Lecturer in Molecular Virology
 
 
 
//

Contact

 

+44 (0)20 7594 3916a.rowan

 
 
//

Location

 

VD4Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Cook:2016:10.1182/blood.V128.22.5356.5356,
author = {Cook, LB and Rowan, AG and Demontis, MA and Marks, S and Bangham, CRM and Fields, P and Taylor, GP},
doi = {10.1182/blood.V128.22.5356.5356},
pages = {5356--5356},
publisher = {American Society of Hematology},
title = {HTLV-1 proviral load after two months' treatment with anti-CCR4 monoclonal antibody mogamulizumab predicts a molecular response to disease and durable clinical remission in leukaemic subtypes of adult T-cell leukaemia/lymphoma},
url = {http://dx.doi.org/10.1182/blood.V128.22.5356.5356},
year = {2016}
}

RIS format (EndNote, RefMan)

TY  - CPAPER
AU - Cook,LB
AU - Rowan,AG
AU - Demontis,MA
AU - Marks,S
AU - Bangham,CRM
AU - Fields,P
AU - Taylor,GP
DO - 10.1182/blood.V128.22.5356.5356
EP - 5356
PB - American Society of Hematology
PY - 2016///
SN - 0006-4971
SP - 5356
TI - HTLV-1 proviral load after two months' treatment with anti-CCR4 monoclonal antibody mogamulizumab predicts a molecular response to disease and durable clinical remission in leukaemic subtypes of adult T-cell leukaemia/lymphoma
UR - http://dx.doi.org/10.1182/blood.V128.22.5356.5356
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394452703115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://www.sciencedirect.com/science/article/pii/S0006497119353571
UR - http://hdl.handle.net/10044/1/104889
ER -